https://www.selleckchem.com/products/md-224.html
Introduction Medication-related osteonecrosis of the jaw (MRONJ) is a serious complication in patients receiving antiresorptive medication, such as bisphosphonates and denosumab, for different oncologic and non-oncologic diseases. Here, we report a case of MRONJ in a patient treated with tocilizumab, a humanized anti-interleukin-6 receptor antibody that effectively treats moderate to severe rheumatoid arthritis in adults. Case description A 45-year-old female patient diagnosed with severe rheumatoid arthritis, who had been undergoing int
Like
Comment
Share
